Publication | Closed Access

Orally administered FTS (salirasib) inhibits human pancreatic tumor growth in nude mice

Tumor BiologyPancreatic CancerNude MiceGastrointestinal OncologyMedicinePharmacologyPathologyPharmacotherapyAnti-cancer AgentOncologyCancer Research